Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nursing Clinical Information System01:27

Nursing Clinical Information System

1.3K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.3K
Clinical Trials01:16

Clinical Trials

10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

3.4K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.4K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

553
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
553

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laccase as a green biocatalyst for xenobiotic degradation: integrative insights from molecular docking and bibliometric analysis.

3 Biotech·2026
Same author

Computational screening of Alternaria metabolites as potential DPP-4 inhibitors: ADMET, molecular docking, molecular dynamics, and network pharmacology analysis.

Molecular diversity·2026
Same author

Anatomy and Spread of Gingivobuccal Cancers.

Oral and maxillofacial surgery clinics of North America·2026
Same author

Exploring the Role of Novel N (4) Substituted 5,7-Dibromoisatin Thiosemicarbazones in Modulating PTOV1 Activity for Therapeutic Relevance in Breast Cancer.

Drug development research·2026
Same author

Percutaneous Minimal Access Approach for Open Reduction and Internal Fixation of Zygomatic Arch in Zygomatic Complex Fractures: A Simple and Effective Technique.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons·2026
Same author

Light-Induced Conformational Switching of 2-Formyl Benzothiazole in Low Temperature Inert Gas Matrices.

Chemphyschem : a European journal of chemical physics and physical chemistry·2026
Same journal

Network Pharmacology and Animal Experimental Validation on the Therapeutic Mechanisms of <i>Prunus cerasifera</i> Extract in Psoriasis.

Clinical, cosmetic and investigational dermatology·2026
Same journal

Evaluation of Parameters Determining the Pull-Out Strength of Poly(L-Lactide-Co-ε-Caprolactone) Barbed Suspension Threads: A Comparative ex vivo Study.

Clinical, cosmetic and investigational dermatology·2026
Same journal

Optimizing Abrocitinib Use for Atopic Dermatitis in India: Expert Recommendations for Patient Selection, Dosing, and Long‑Term Remission.

Clinical, cosmetic and investigational dermatology·2026
Same journal

Evolving Research Hotspots and Emerging Trends in Atopic Dermatitis and Inflammatory Bowel Disease: A Bibliometric Analysis.

Clinical, cosmetic and investigational dermatology·2026
Same journal

A Preliminary Study of Polycaprolactone Filler After Hyaluronidase for Facial Overfilled Syndrome.

Clinical, cosmetic and investigational dermatology·2026
Same journal

Successful Treatment of Extensive Ritlecitinib-Refractory Alopecia Areata with Upadacitinib.

Clinical, cosmetic and investigational dermatology·2026
See all related articles

Related Experiment Video

Updated: Jan 23, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.6K

Epidermolytic hyperkeratosis: clinical update.

Denice Peter Rout1, Anushka Nair1, Anand Gupta1

  • 1Amity Institute of Biotechnology, Amity University Mumbai, Navi Mumbai, India.

Clinical, Cosmetic and Investigational Dermatology
|June 14, 2019
PubMed
Summary
This summary is machine-generated.

Epidermolytic hyperkeratosis (EHK) is a rare genetic skin disorder caused by keratin gene mutations. This review covers EHK

Keywords:
epidermolytic hyperkeratosisichthyosisskinskin disorder

More Related Videos

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)
09:38

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)

Published on: September 5, 2025

856
Updated Technique for Reliable, Easy, and Tolerated Transcranial Electrical Stimulation Including Transcranial Direct Current Stimulation
10:11

Updated Technique for Reliable, Easy, and Tolerated Transcranial Electrical Stimulation Including Transcranial Direct Current Stimulation

Published on: January 3, 2020

11.8K

Related Experiment Videos

Last Updated: Jan 23, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.6K
Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)
09:38

Updated Protocol for the Assembly and Use of the Minibioreactor Array (MBRA)

Published on: September 5, 2025

856
Updated Technique for Reliable, Easy, and Tolerated Transcranial Electrical Stimulation Including Transcranial Direct Current Stimulation
10:11

Updated Technique for Reliable, Easy, and Tolerated Transcranial Electrical Stimulation Including Transcranial Direct Current Stimulation

Published on: January 3, 2020

11.8K

Area of Science:

  • Dermatology
  • Genetics
  • Molecular Biology

Background:

  • Epidermolytic hyperkeratosis (EHK), previously bullous congenital ichthyosiform erythroderma, is a rare autosomal dominant skin disorder.
  • Affecting approximately 1 in 200,000 infants, EHK results from mutations in keratin genes, primarily KRT1 and KRT10.
  • Clinical manifestations include congenital erythema and blistering, progressing to hyperkeratosis, erosions, and blisters in adults, causing significant psychological distress.

Purpose of the Study:

  • To review subtypes of ichthyosis, focusing on Epidermolytic hyperkeratosis (EHK).
  • To explore the genetic basis, recent mutations, and diagnostic/therapeutic strategies for EHK.
  • To discuss the potential of novel diagnostic and treatment modalities for EHK.

Main Methods:

  • Review of existing literature on ichthyosis subtypes, with a specific focus on EHK.
  • Analysis of genetic mutations associated with EHK, including recently reported cases.
  • Evaluation of current diagnostic methods (clinical inspection, histopathology, electron microscopy) and treatments.
  • Exploration of emerging diagnostic and therapeutic approaches.

Main Results:

  • EHK is characterized by specific genetic mutations in keratin genes.
  • Current diagnostic methods include clinical examination and specialized tests.
  • Existing treatments aim to manage symptoms, but further improvements are needed.
  • Novel diagnostic and therapeutic strategies show potential for better EHK management.

Conclusions:

  • EHK is a complex genetic disorder requiring comprehensive understanding.
  • Improved diagnostic accuracy and advanced treatment options are crucial for managing EHK.
  • Further research into novel therapeutic modalities is warranted to enhance patient outcomes.